wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38340201-1462D0BC-D7C3-48F2-9E6E-D7DA29168CBC
Q38340201-1462D0BC-D7C3-48F2-9E6E-D7DA29168CBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38340201-1462D0BC-D7C3-48F2-9E6E-D7DA29168CBC
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
P2860
Q38340201-1462D0BC-D7C3-48F2-9E6E-D7DA29168CBC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38340201-1462D0BC-D7C3-48F2-9E6E-D7DA29168CBC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbe441ea2583e6b25405df15e568e1f1aac298a8
P2860
Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.